BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28067163)

  • 1. HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy.
    Floridia M; Masuelli G; Tamburrini E; Spinillo A; Simonazzi G; Guaraldi G; Degli Antoni AM; Martinelli P; Portelli V; Dalzero S; Ravizza M
    HIV Clin Trials; 2017 Mar; 18(2):54-59. PubMed ID: 28067163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
    Benhammou V; Tubiana R; Matheron S; Sellier P; Mandelbrot L; Chenadec JL; Marel E; Khoshnood B; Warszawski J;
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):439-450. PubMed ID: 29287028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
    De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
    Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy.
    Malagnino V; Cerva C; Maffongelli G; Teti E; Foroghi Biland L; Cesta N; De Masi M; Stingone C; Armenia D; Svicher V; Salpini R; Andreoni M; Sarmati L
    Sci Rep; 2019 Aug; 9(1):11942. PubMed ID: 31420570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions.
    Neukam K; Gutiérrez-Valencia A; Llaves-Flores S; Espinosa N; Viciana P; López-Cortés LF
    Vaccine; 2019 May; 37(20):2758-2763. PubMed ID: 30981625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers.
    Malagnino V; Cerva C; Teti E; Campogiani L; Compagno M; Foroghi Biland L; Saderi L; Armenia D; Salpini R; Svicher V; Sotgiu G; Iannetta M; Andreoni M; Sarmati L
    Sci Rep; 2021 Feb; 11(1):3965. PubMed ID: 33597631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir-based antiretroviral therapy in 
HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database.
    Boettiger DC; Kerr S; Ditangco R; Chaiwarith R; Li PC; Merati TP; Pham TT; Kiertiburanakul S; Kumarasamy N; Vonthanak S; Lee CK; Van Kinh N; Pujari S; Wong WW; Kamarulzaman A; Zhang F; Yunihastuti E; Choi JY; Oka S; Ng OT; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Law M;
    Antivir Ther; 2016; 21(1):27-35. PubMed ID: 26069150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHARACTERISTICS OF HEPATITIS B VIRUS COINFECTION AMONG HIV-INFECTED PREGNANT WOMEN.
    Juganariu G; Teodor A; Petrovici C; Cristina N; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1010-7. PubMed ID: 26793842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated pre-treatment IL-18 level is associated with HBeAg seroconversion in HIV-HBV coinfection.
    Li Y; Xie J; Wang H; Han Y; Wang N; Thio CL; Li T
    Antivir Ther; 2017; 22(6):523-527. PubMed ID: 28195558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy.
    Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E;
    Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.
    Sagoe KW; Duedu KO; Ziga F; Agyei AA; Adiku TK; Lartey M; Mingle JA; Arens M
    Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):38. PubMed ID: 27251610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.
    Lincoln D; Petoumenos K; Dore GJ;
    HIV Med; 2003 Jul; 4(3):241-9. PubMed ID: 12859323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
    Bivigou-Mboumba B; François-Souquière S; Deleplancque L; Sica J; Mouinga-Ondémé A; Amougou-Atsama M; Chaix ML; Njouom R; Rouet F
    PLoS One; 2016; 11(1):e0143869. PubMed ID: 26764909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immuno-deficiency virus and hepatitis B virus coinfection in pregnancy at the University College Hospital, Ibadan.
    Adesina O; Oladokun A; Akinyemi O; Adedokun B; Awolude O; Odaibo G; Olaleye D; Adewole I
    Afr J Med Med Sci; 2010 Dec; 39(4):305-10. PubMed ID: 21735996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study.
    Silva CMD; Peder LD; Silva ES; Previdelli I; Pereira OCN; Teixeira JJV; Bertolini DA
    J Infect Dev Ctries; 2018 Nov; 12(11):1009-1018. PubMed ID: 32012132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
    Castagna A; Galli L; Torti C; D'Arminio Monforte A; Mussini C; Antinori A; Cozzi-Lepri A; Ladisa N; De Luca A; Seminari E; Gianotti N; Lazzarin A
    Antivir Ther; 2010; 15(2):165-75. PubMed ID: 20386071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort.
    Wang H; Li Y; Zhang C; Han Y; Zhang X; Zhu T; Li T
    AIDS; 2012 Sep; 26(14):1755-63. PubMed ID: 22614885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.